As of Oct 12, 2026 close
- Market cap
- $390.53M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.65$13.25
- Volume (live)
- -
- Avg. volume (3M)
- 182.39K
Fennec Pharmaceuticals (FENC) Stock Price & Financial Analysis
Fennec Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.42 - $10.83 |
|---|---|
| 52-Week High | $13.25 |
| 52-Week Low | $5.65 |
| Open | $10.68 |
| Volume (last close) | 90.13K |
| Average Volume (3M) | 182.39K |
| Market Cap | 390.53M |
|---|---|
| Shares Outstanding | 36.43M |
| Price to Sales (P/S) | 6.59 |
| Price to Book (P/B) | 9.20 |
| EV/EBITDA | -166.64 |
| Revenue (TTM) | 59.22M |
|---|---|
| Net Income (TTM) | -3.25M |
| Free Cash Flow (TTM) | -2.04M |
| EPS (TTM) | $-0.10 |
| Profit Margin | -5.49% |
| Operating Margin | -1.96% |
| Return on Equity (ROE) | -7.66% |
| Debt to Equity | 0.00 |
| 50-Day MA | $11.22 |
|---|---|
| 200-Day MA | $9.02 |
| 1-Year Change | +27.01% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Fennec Pharmaceuticals at a Glance
Fennec Pharmaceuticals (FENC) has a market capitalization of $390.53M. The stock trades at 6.6× sales. Over the trailing twelve months it lost $3.25M on revenue of $59.22M and burned $2.04M of free cash flow. Revenue grew 77.8% year over year.
It holds $41.25M in cash and securities against $0.00 of debt, a net cash position of $41.25M.
Fennec Pharmaceuticals does not currently pay a dividend.
The share price is up 27.0% over the past year. At $10.72 it sits within its 52-week range of $5.65 to $13.25, above its 200-day moving average of $9.02.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $17.60, 64.2% above the latest close.
Frequently Asked Questions About Fennec Pharmaceuticals
What is the current stock price for FENC?
As of the Oct 12, 2026 close, FENC stock trades at $10.72. The 52-week range is $5.65–$13.25, with a day range of $10.42–$10.83.
What is the P/E ratio for FENC?
The P/E ratio (Price-to-Earnings) for FENC is shown in the Key Statistics section. This valuation metric helps compare Fennec Pharmaceuticals Inc. to industry peers.
Does FENC pay dividends?
Fennec Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for FENC?
Based on 6 analysts, the consensus for FENC is Buy.
What is the market cap of FENC?
Fennec Pharmaceuticals's market capitalization is $390.5M, classifying it as a small-cap company. Fennec Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.